Search Results - "Sonecha, S"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Safety and efficacy of fixed‐dose combination rilpivirine‐tenofovir‐emtricitabine (RPV/TDF/FTC) in treatment‐experienced patients infected with HIV‐1 by Cevik, M, Sonecha, S, Nelson, M

    Published in Journal of the International AIDS Society (01-11-2012)
    “…Purpose of the study Rilpivirine (RPV) is a new non‐nucleoside reverse transcriptase inhibitor (NNRTI) which has shown non‐inferiority to efavirenz (EFV) in…”
    Get full text
    Journal Article
  6. 6

    The impact of introducing a satellite dispensary service at an outpatient HIV clinic by Vekeria, S, Jalali, F, Sonecha, S, Bates, I

    Published in Journal of the International AIDS Society (01-11-2012)
    “…Background Studies have demonstrated the potential impact of pharmaceutical services in HIV care [1]. We sought to extend HIV pharmacy services at the Dean…”
    Get full text
    Journal Article
  7. 7

    A survey of patients’ willingness to switch from a single‐tablet regimen to 2 pills once a day as a cost‐saving strategy by Tan, J, Sonecha, S, Mandalia, S, Nelson, M

    Published in Journal of the International AIDS Society (01-11-2012)
    “…With the patent on efavirenz due to expire a potential cost‐saving strategy is to switch HIV‐infected patients who are stable on Atripla® (tenofovir,…”
    Get full text
    Journal Article
  8. 8

    An investigation into frequency and reasons why patients switch antiretroviral therapy and which antiretrovirals are commonly implicated in toxicity by Boyle, A, Sonecha, S, Mandalia, S, Nelson, M

    Published in Journal of the International AIDS Society (01-11-2012)
    “…Purpose of the study Previous investigation into antiretroviral (ARV) therapy switches in our HIV cohort suggested an annual switch rate of 20% in 2006 with…”
    Get full text
    Journal Article
  9. 9
  10. 10